Hansa Biopharma AB, ("Hansa" or "the Company"), (Nasdaq Stockholm: HNSA), today announced that its Biologics License Application (BLA) for imlifidase ...

This medical technology stock is back in a buy zone and nearing its all-time high.

Researchers introduced a yeast enzyme, ScURA, into human cells, enabling nucleotide synthesis independent of mitochondrial respiration. The modified cells proliferated normally without uridine ...

A study using Ribo-STAMP technology reveals that protein production in brain cells varies significantly between different types of neurons, offering new insights into autism and memory.

Researchers developed C28, an engineered polymerase that efficiently synthesizes RNA at near-natural speeds with high ...

Oncology Strategy and Expands Intellectual Property Foundation for Combination Therapies Across Solid Tumors ATLANTA, GA - ...

The brain's ability to carry out everything from forming memories to coordinating movement depends on its cells producing the right proteins at the right time. But directly measuring this protein ...

Bringing the cutting-edge technology of enzymes to the dish soap aisle, method is introducing a new way to tackle the dishes—one that targets tough stains from starches, fats, and proteins for a more ...

The brain's ability to do everything from forming memories to coordinating movement relies on its cells producing the right proteins at the right time. But directly measuring this protein production, ...

Sustained acoustic medicine (sam®) helps players recover more quickly from workouts and injuries, such as the UCL tears, hamstring pulls, and oblique strains that are becoming more common in baseball.

Caring Brands Inc. (Nasdaq: CABR) today announced the issuance of two new United States patents covering proprietary methods ...

Analysis from continued follow-up of Phase 1/2 clinical trial data in Hunter syndrome (MPS II) reinforces potential for tividenofusp alfa ...